Jeri Forster
Concepts (482)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Veterans | 77 | 2025 | 1398 | 7.870 |
Why?
| Suicidal Ideation | 22 | 2025 | 462 | 2.950 |
Why?
| Brain Injuries, Traumatic | 16 | 2025 | 337 | 2.860 |
Why?
| Suicide | 16 | 2024 | 578 | 2.810 |
Why?
| Brain Injuries | 10 | 2022 | 463 | 1.760 |
Why?
| Brain Concussion | 15 | 2025 | 548 | 1.700 |
Why?
| Sex Offenses | 7 | 2023 | 178 | 1.660 |
Why?
| Military Personnel | 11 | 2024 | 514 | 1.500 |
Why?
| Stress Disorders, Post-Traumatic | 17 | 2025 | 822 | 1.360 |
Why?
| Sleep Initiation and Maintenance Disorders | 7 | 2024 | 146 | 1.320 |
Why?
| Suicide, Attempted | 10 | 2021 | 349 | 1.290 |
Why?
| United States Department of Veterans Affairs | 18 | 2024 | 634 | 1.270 |
Why?
| Post-Concussion Syndrome | 5 | 2024 | 166 | 1.000 |
Why?
| United States | 58 | 2025 | 13830 | 1.000 |
Why?
| Arthroplasty, Replacement, Knee | 8 | 2025 | 300 | 0.990 |
Why?
| Self-Injurious Behavior | 4 | 2020 | 120 | 0.970 |
Why?
| Home Care Services | 8 | 2024 | 244 | 0.960 |
Why?
| Physical Therapy Modalities | 10 | 2024 | 293 | 0.950 |
Why?
| Activities of Daily Living | 7 | 2024 | 384 | 0.900 |
Why?
| Skilled Nursing Facilities | 6 | 2023 | 129 | 0.850 |
Why?
| Middle Aged | 72 | 2025 | 30889 | 0.850 |
Why?
| Humans | 146 | 2025 | 128418 | 0.810 |
Why?
| Female | 103 | 2025 | 68154 | 0.800 |
Why?
| Aftercare | 2 | 2021 | 206 | 0.800 |
Why?
| Patient Discharge | 12 | 2024 | 853 | 0.780 |
Why?
| Mental Disorders | 8 | 2024 | 1027 | 0.780 |
Why?
| Male | 100 | 2025 | 62858 | 0.780 |
Why?
| Psychometrics | 7 | 2024 | 681 | 0.770 |
Why?
| Aged | 49 | 2025 | 21953 | 0.760 |
Why?
| Sexual Harassment | 3 | 2016 | 26 | 0.750 |
Why?
| Adult | 66 | 2025 | 35300 | 0.710 |
Why?
| Embolism, Fat | 1 | 2020 | 11 | 0.690 |
Why?
| Social Support | 1 | 2024 | 589 | 0.660 |
Why?
| Hospitalization | 10 | 2024 | 2057 | 0.640 |
Why?
| Occupational Therapy | 4 | 2024 | 85 | 0.630 |
Why?
| Exercise Therapy | 7 | 2025 | 413 | 0.560 |
Why?
| Firearms | 1 | 2022 | 359 | 0.530 |
Why?
| Cross-Sectional Studies | 17 | 2023 | 5039 | 0.520 |
Why?
| Sleep Apnea, Obstructive | 3 | 2024 | 238 | 0.510 |
Why?
| Retrospective Studies | 31 | 2025 | 14454 | 0.510 |
Why?
| Resistance Training | 3 | 2024 | 151 | 0.510 |
Why?
| Death | 1 | 2016 | 121 | 0.500 |
Why?
| Arthroplasty, Replacement, Hip | 3 | 2024 | 135 | 0.500 |
Why?
| Neuropsychological Tests | 4 | 2019 | 1002 | 0.490 |
Why?
| Patient Dropouts | 2 | 2015 | 64 | 0.490 |
Why?
| Risk Factors | 17 | 2024 | 9704 | 0.480 |
Why?
| Multimorbidity | 2 | 2025 | 46 | 0.460 |
Why?
| Osteoarthritis, Knee | 3 | 2025 | 239 | 0.450 |
Why?
| Health Personnel | 4 | 2024 | 644 | 0.450 |
Why?
| Executive Function | 3 | 2017 | 422 | 0.440 |
Why?
| Walking Speed | 3 | 2024 | 44 | 0.430 |
Why?
| Fear | 1 | 2016 | 325 | 0.430 |
Why?
| Muscle Strength | 5 | 2024 | 305 | 0.420 |
Why?
| Burnout, Professional | 3 | 2024 | 407 | 0.420 |
Why?
| Veterans Health | 6 | 2023 | 175 | 0.410 |
Why?
| Biofeedback, Psychology | 2 | 2025 | 33 | 0.400 |
Why?
| Biometry | 1 | 2011 | 69 | 0.370 |
Why?
| Probability | 1 | 2011 | 305 | 0.350 |
Why?
| Sleep Wake Disorders | 3 | 2022 | 250 | 0.350 |
Why?
| Recovery of Function | 7 | 2025 | 641 | 0.350 |
Why?
| Referral and Consultation | 1 | 2015 | 727 | 0.340 |
Why?
| Aged, 80 and over | 15 | 2024 | 7033 | 0.330 |
Why?
| Multiple Sclerosis | 3 | 2024 | 436 | 0.330 |
Why?
| Physical and Rehabilitation Medicine | 2 | 2021 | 30 | 0.330 |
Why?
| Patient Readmission | 4 | 2024 | 664 | 0.330 |
Why?
| Anti-HIV Agents | 3 | 2015 | 747 | 0.320 |
Why?
| Depressive Disorder, Major | 2 | 2024 | 342 | 0.320 |
Why?
| Young Adult | 13 | 2024 | 12312 | 0.320 |
Why?
| Health Services Accessibility | 3 | 2024 | 896 | 0.320 |
Why?
| Exercise | 4 | 2021 | 1929 | 0.310 |
Why?
| Depression | 7 | 2024 | 1296 | 0.310 |
Why?
| Models, Statistical | 2 | 2015 | 621 | 0.310 |
Why?
| Electric Impedance | 2 | 2019 | 101 | 0.310 |
Why?
| Sex Factors | 5 | 2024 | 1945 | 0.300 |
Why?
| Edema | 2 | 2019 | 125 | 0.300 |
Why?
| Chronic Pain | 2 | 2024 | 254 | 0.290 |
Why?
| Lower Extremity | 3 | 2024 | 402 | 0.280 |
Why?
| Factor Analysis, Statistical | 5 | 2024 | 283 | 0.280 |
Why?
| September 11 Terrorist Attacks | 2 | 2025 | 32 | 0.280 |
Why?
| Randomized Controlled Trials as Topic | 6 | 2024 | 1356 | 0.270 |
Why?
| Patient Compliance | 4 | 2024 | 560 | 0.270 |
Why?
| Anxiety | 4 | 2024 | 955 | 0.270 |
Why?
| Prospective Studies | 7 | 2023 | 7036 | 0.270 |
Why?
| Occupational Diseases | 2 | 2019 | 138 | 0.260 |
Why?
| Risk | 5 | 2023 | 853 | 0.260 |
Why?
| HIV Infections | 7 | 2015 | 2701 | 0.250 |
Why?
| Postural Balance | 2 | 2018 | 199 | 0.250 |
Why?
| Subacute Care | 3 | 2021 | 77 | 0.250 |
Why?
| Disability Evaluation | 2 | 2020 | 286 | 0.240 |
Why?
| Longitudinal Studies | 7 | 2024 | 2710 | 0.240 |
Why?
| Pilot Projects | 7 | 2023 | 1564 | 0.240 |
Why?
| Gait | 2 | 2024 | 281 | 0.240 |
Why?
| Decision Making | 3 | 2024 | 847 | 0.230 |
Why?
| Art Therapy | 1 | 2024 | 17 | 0.230 |
Why?
| Medicare | 5 | 2021 | 715 | 0.230 |
Why?
| Gastrointestinal Microbiome | 2 | 2023 | 633 | 0.230 |
Why?
| Enterobacter cloacae | 1 | 2024 | 3 | 0.230 |
Why?
| Telerehabilitation | 1 | 2025 | 36 | 0.230 |
Why?
| Walk Test | 1 | 2024 | 69 | 0.230 |
Why?
| Adolescent | 12 | 2024 | 20179 | 0.230 |
Why?
| Self Report | 6 | 2019 | 801 | 0.220 |
Why?
| Osteoarthritis, Hip | 1 | 2024 | 43 | 0.220 |
Why?
| Patient Health Questionnaire | 1 | 2024 | 36 | 0.220 |
Why?
| Seasonal Affective Disorder | 1 | 2023 | 10 | 0.220 |
Why?
| Continuous Positive Airway Pressure | 1 | 2024 | 69 | 0.220 |
Why?
| Enterobacteriaceae Infections | 1 | 2024 | 36 | 0.220 |
Why?
| Luteinizing Hormone | 2 | 2023 | 178 | 0.210 |
Why?
| Feasibility Studies | 6 | 2025 | 860 | 0.210 |
Why?
| Frail Elderly | 1 | 2024 | 121 | 0.200 |
Why?
| Iraq War, 2003-2011 | 5 | 2024 | 125 | 0.200 |
Why?
| Health Services Needs and Demand | 2 | 2021 | 264 | 0.200 |
Why?
| Antidepressive Agents | 1 | 2024 | 221 | 0.200 |
Why?
| Geriatric Assessment | 2 | 2024 | 205 | 0.200 |
Why?
| Case-Control Studies | 6 | 2022 | 3328 | 0.200 |
Why?
| Comorbidity | 6 | 2024 | 1543 | 0.190 |
Why?
| Cross Infection | 1 | 2024 | 195 | 0.190 |
Why?
| Residence Characteristics | 1 | 2025 | 326 | 0.190 |
Why?
| Prevalence | 5 | 2021 | 2547 | 0.190 |
Why?
| Ownership | 1 | 2022 | 87 | 0.190 |
Why?
| Age Factors | 3 | 2024 | 3103 | 0.190 |
Why?
| Reproducibility of Results | 5 | 2022 | 3020 | 0.190 |
Why?
| Psychological Trauma | 1 | 2022 | 54 | 0.190 |
Why?
| Nutritional Status | 1 | 2024 | 325 | 0.190 |
Why?
| Pregnancy Complications, Infectious | 2 | 2016 | 364 | 0.190 |
Why?
| Health Knowledge, Attitudes, Practice | 3 | 2024 | 1275 | 0.190 |
Why?
| Knee Joint | 1 | 2025 | 366 | 0.190 |
Why?
| Nerve Compression Syndromes | 1 | 2021 | 24 | 0.190 |
Why?
| Radiculopathy | 1 | 2021 | 33 | 0.180 |
Why?
| Psychiatric Status Rating Scales | 3 | 2018 | 528 | 0.180 |
Why?
| Frailty | 1 | 2024 | 153 | 0.180 |
Why?
| Stroke Rehabilitation | 1 | 2021 | 40 | 0.180 |
Why?
| Physical Abuse | 1 | 2021 | 39 | 0.180 |
Why?
| Glasgow Outcome Scale | 1 | 2020 | 8 | 0.170 |
Why?
| Women | 1 | 2021 | 52 | 0.170 |
Why?
| Internship and Residency | 2 | 2021 | 1048 | 0.170 |
Why?
| Survivors | 2 | 2021 | 463 | 0.170 |
Why?
| Amyotrophic Lateral Sclerosis | 1 | 2021 | 67 | 0.170 |
Why?
| Peripheral Nervous System Diseases | 1 | 2021 | 123 | 0.170 |
Why?
| Risk Assessment | 7 | 2020 | 3232 | 0.170 |
Why?
| Substance-Related Disorders | 2 | 2023 | 1013 | 0.170 |
Why?
| Single-Blind Method | 4 | 2024 | 267 | 0.170 |
Why?
| Inpatients | 3 | 2024 | 465 | 0.170 |
Why?
| Students, Health Occupations | 1 | 2020 | 28 | 0.160 |
Why?
| Glasgow Coma Scale | 1 | 2020 | 167 | 0.160 |
Why?
| Mobility Limitation | 1 | 2020 | 61 | 0.160 |
Why?
| Value of Life | 2 | 2016 | 17 | 0.160 |
Why?
| Walking | 3 | 2024 | 494 | 0.160 |
Why?
| Arthroplasty, Replacement | 1 | 2020 | 48 | 0.160 |
Why?
| Outpatients | 3 | 2023 | 366 | 0.160 |
Why?
| Competency-Based Education | 1 | 2020 | 70 | 0.160 |
Why?
| Myofascial Pain Syndromes | 1 | 2019 | 11 | 0.160 |
Why?
| Electromyography | 1 | 2021 | 379 | 0.160 |
Why?
| Medicine | 1 | 2021 | 118 | 0.160 |
Why?
| Transitional Care | 1 | 2019 | 37 | 0.160 |
Why?
| Pelvic Pain | 1 | 2019 | 34 | 0.160 |
Why?
| Speech Discrimination Tests | 1 | 2018 | 3 | 0.150 |
Why?
| Mental Health Services | 4 | 2024 | 404 | 0.150 |
Why?
| Drug Overdose | 1 | 2023 | 319 | 0.150 |
Why?
| Health Services for the Aged | 1 | 2019 | 72 | 0.150 |
Why?
| Physical Therapists | 1 | 2019 | 61 | 0.150 |
Why?
| Sense of Coherence | 1 | 2018 | 11 | 0.150 |
Why?
| Hope | 1 | 2018 | 22 | 0.150 |
Why?
| Afghan Campaign 2001- | 4 | 2022 | 130 | 0.150 |
Why?
| Healthcare Disparities | 1 | 2024 | 579 | 0.150 |
Why?
| Professional Role | 1 | 2019 | 160 | 0.140 |
Why?
| Eye Movements | 1 | 2018 | 59 | 0.140 |
Why?
| Socioeconomic Factors | 3 | 2020 | 1212 | 0.140 |
Why?
| Educational Measurement | 1 | 2020 | 261 | 0.140 |
Why?
| Combat Disorders | 1 | 2017 | 37 | 0.140 |
Why?
| Drug Packaging | 1 | 2017 | 40 | 0.140 |
Why?
| Prefrontal Cortex | 2 | 2017 | 299 | 0.140 |
Why?
| Speech Perception | 1 | 2018 | 82 | 0.140 |
Why?
| Personality Assessment | 1 | 2017 | 81 | 0.140 |
Why?
| Parkinson Disease | 1 | 2022 | 460 | 0.130 |
Why?
| Range of Motion, Articular | 3 | 2025 | 386 | 0.130 |
Why?
| Visual Perception | 1 | 2018 | 162 | 0.130 |
Why?
| Depressive Disorder | 2 | 2018 | 360 | 0.130 |
Why?
| War Exposure | 1 | 2016 | 10 | 0.130 |
Why?
| Pain Measurement | 1 | 2019 | 487 | 0.130 |
Why?
| Joint Instability | 1 | 2019 | 182 | 0.130 |
Why?
| Patient Safety | 1 | 2020 | 287 | 0.130 |
Why?
| Nelfinavir | 1 | 2016 | 9 | 0.130 |
Why?
| Severity of Illness Index | 3 | 2019 | 2722 | 0.130 |
Why?
| Vaccines, DNA | 2 | 2008 | 28 | 0.130 |
Why?
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 1996 | 40 | 0.130 |
Why?
| Hypertension, Portal | 1 | 1996 | 60 | 0.130 |
Why?
| Lopinavir | 1 | 2016 | 30 | 0.130 |
Why?
| Atazanavir Sulfate | 1 | 2016 | 41 | 0.130 |
Why?
| HIV-1 | 3 | 2008 | 836 | 0.130 |
Why?
| AIDS Vaccines | 2 | 2008 | 47 | 0.130 |
Why?
| Pharmacovigilance | 1 | 2015 | 21 | 0.130 |
Why?
| Microbiota | 1 | 2023 | 719 | 0.130 |
Why?
| Attitude to Death | 1 | 2016 | 67 | 0.130 |
Why?
| HIV Protease Inhibitors | 1 | 2016 | 62 | 0.130 |
Why?
| Child | 8 | 2024 | 20655 | 0.120 |
Why?
| Clinical Competence | 2 | 2020 | 1013 | 0.120 |
Why?
| Ritonavir | 1 | 2016 | 72 | 0.120 |
Why?
| Actigraphy | 1 | 2016 | 94 | 0.120 |
Why?
| T-Lymphocytes, Cytotoxic | 2 | 2008 | 168 | 0.120 |
Why?
| Medical Records | 1 | 2016 | 170 | 0.120 |
Why?
| Adverse Drug Reaction Reporting Systems | 1 | 2015 | 74 | 0.120 |
Why?
| Hearing Loss | 1 | 2018 | 210 | 0.120 |
Why?
| Warfare | 1 | 2015 | 63 | 0.120 |
Why?
| Medication Errors | 1 | 2015 | 95 | 0.120 |
Why?
| Thalamus | 1 | 2015 | 84 | 0.120 |
Why?
| Epitopes, T-Lymphocyte | 2 | 2008 | 185 | 0.120 |
Why?
| Surveys and Questionnaires | 6 | 2018 | 5362 | 0.120 |
Why?
| Infant, Newborn, Diseases | 1 | 2016 | 108 | 0.110 |
Why?
| Videotape Recording | 1 | 1994 | 34 | 0.110 |
Why?
| Violence | 1 | 2017 | 240 | 0.110 |
Why?
| Cohort Studies | 6 | 2021 | 5388 | 0.110 |
Why?
| Dizziness | 3 | 2019 | 80 | 0.110 |
Why?
| Ozone | 3 | 2000 | 103 | 0.110 |
Why?
| Ambulatory Surgical Procedures | 1 | 1994 | 55 | 0.110 |
Why?
| Risk-Taking | 2 | 2017 | 347 | 0.110 |
Why?
| Complementary Therapies | 1 | 2014 | 86 | 0.110 |
Why?
| Liver Diseases | 1 | 1996 | 284 | 0.110 |
Why?
| Cerebellum | 1 | 2015 | 217 | 0.110 |
Why?
| Infectious Disease Transmission, Vertical | 1 | 2015 | 170 | 0.110 |
Why?
| Injury Severity Score | 1 | 2015 | 510 | 0.110 |
Why?
| Iraq | 2 | 2024 | 53 | 0.110 |
Why?
| Pandemics | 1 | 2021 | 1476 | 0.100 |
Why?
| Hypertension | 1 | 2022 | 1235 | 0.100 |
Why?
| Afghanistan | 2 | 2024 | 71 | 0.100 |
Why?
| Drug-Related Side Effects and Adverse Reactions | 1 | 2015 | 253 | 0.100 |
Why?
| Thinness | 1 | 2013 | 90 | 0.100 |
Why?
| Analgesics, Opioid | 2 | 2023 | 887 | 0.100 |
Why?
| Athletic Injuries | 1 | 2019 | 517 | 0.100 |
Why?
| Emotions | 1 | 2018 | 535 | 0.100 |
Why?
| Medication Adherence | 1 | 2017 | 560 | 0.100 |
Why?
| Decision Support Systems, Clinical | 1 | 2015 | 206 | 0.100 |
Why?
| Fatigue | 3 | 2019 | 317 | 0.100 |
Why?
| Treatment Outcome | 6 | 2025 | 10152 | 0.100 |
Why?
| Quality Improvement | 1 | 2020 | 1094 | 0.100 |
Why?
| Time Factors | 5 | 2021 | 6482 | 0.100 |
Why?
| Preoperative Care | 1 | 1994 | 338 | 0.100 |
Why?
| Interpersonal Relations | 1 | 2015 | 388 | 0.090 |
Why?
| Wounds and Injuries | 1 | 2018 | 707 | 0.090 |
Why?
| Quadriceps Muscle | 2 | 2024 | 128 | 0.090 |
Why?
| Tertiary Care Centers | 2 | 2024 | 146 | 0.090 |
Why?
| Mental Health | 3 | 2023 | 686 | 0.090 |
Why?
| Postoperative Complications | 2 | 2019 | 2485 | 0.090 |
Why?
| Attitude to Health | 1 | 1994 | 431 | 0.090 |
Why?
| HIV | 1 | 2011 | 225 | 0.090 |
Why?
| Bayes Theorem | 2 | 2022 | 369 | 0.090 |
Why?
| Glucose | 1 | 2015 | 982 | 0.090 |
Why?
| Hospitals, Veterans | 3 | 2019 | 256 | 0.090 |
Why?
| Receptors, CXCR4 | 2 | 2007 | 82 | 0.080 |
Why?
| Epilepsy | 1 | 2014 | 322 | 0.080 |
Why?
| Cross-Over Studies | 2 | 2025 | 513 | 0.080 |
Why?
| Cognition | 3 | 2023 | 1107 | 0.080 |
Why?
| Magnetic Resonance Imaging | 1 | 2021 | 3376 | 0.080 |
Why?
| Adipose Tissue | 1 | 2013 | 589 | 0.080 |
Why?
| Patient Education as Topic | 1 | 1994 | 737 | 0.080 |
Why?
| Analysis of Variance | 3 | 2019 | 1269 | 0.080 |
Why?
| Oxidants, Photochemical | 2 | 1999 | 6 | 0.080 |
Why?
| Length of Stay | 1 | 2014 | 1113 | 0.080 |
Why?
| Attitude of Health Personnel | 1 | 2016 | 1093 | 0.070 |
Why?
| Seasons | 3 | 2000 | 497 | 0.070 |
Why?
| Colorado | 4 | 2023 | 4375 | 0.070 |
Why?
| RNA, Viral | 1 | 2011 | 616 | 0.070 |
Why?
| Qualitative Research | 2 | 2024 | 1226 | 0.070 |
Why?
| Interviews as Topic | 2 | 2024 | 715 | 0.070 |
Why?
| Trauma Severity Indices | 2 | 2019 | 104 | 0.070 |
Why?
| Parents | 1 | 2015 | 1304 | 0.070 |
Why?
| Interferon-gamma | 2 | 2008 | 759 | 0.070 |
Why?
| Prion Diseases | 1 | 2006 | 15 | 0.070 |
Why?
| alpha-Defensins | 1 | 2006 | 10 | 0.070 |
Why?
| Creutzfeldt-Jakob Syndrome | 1 | 2006 | 19 | 0.070 |
Why?
| Wasting Disease, Chronic | 1 | 2006 | 24 | 0.070 |
Why?
| Granulocytes | 1 | 2006 | 79 | 0.070 |
Why?
| CD4-Positive T-Lymphocytes | 2 | 2015 | 1046 | 0.070 |
Why?
| Lymphoid Tissue | 1 | 2006 | 68 | 0.060 |
Why?
| Germany | 2 | 2024 | 97 | 0.060 |
Why?
| Quality of Life | 3 | 2024 | 2680 | 0.060 |
Why?
| Follicle Stimulating Hormone | 2 | 2023 | 235 | 0.060 |
Why?
| Interleukin-18 | 1 | 2007 | 236 | 0.060 |
Why?
| Anti-Retroviral Agents | 1 | 2007 | 230 | 0.060 |
Why?
| Models, Psychological | 2 | 2018 | 306 | 0.060 |
Why?
| Mass Screening | 1 | 2013 | 1147 | 0.060 |
Why?
| Insulin Resistance | 1 | 2013 | 1164 | 0.060 |
Why?
| Infant, Newborn | 4 | 2024 | 5687 | 0.060 |
Why?
| Emergency Service, Hospital | 1 | 2015 | 1901 | 0.060 |
Why?
| Exercise Test | 2 | 2019 | 613 | 0.060 |
Why?
| Sex Distribution | 2 | 2023 | 358 | 0.060 |
Why?
| Treatment Adherence and Compliance | 1 | 2024 | 23 | 0.060 |
Why?
| Rehabilitation Centers | 1 | 2024 | 37 | 0.060 |
Why?
| Algorithms | 1 | 2011 | 1618 | 0.060 |
Why?
| Phototherapy | 1 | 2023 | 29 | 0.060 |
Why?
| Cytotoxicity Tests, Immunologic | 1 | 2003 | 42 | 0.060 |
Why?
| Hand Strength | 1 | 2024 | 113 | 0.050 |
Why?
| Epidemiological Monitoring | 1 | 2024 | 49 | 0.050 |
Why?
| Follow-Up Studies | 4 | 2018 | 4892 | 0.050 |
Why?
| Crisis Intervention | 1 | 2023 | 33 | 0.050 |
Why?
| Triamcinolone Acetonide | 1 | 2023 | 27 | 0.050 |
Why?
| Multiple Trauma | 1 | 2024 | 103 | 0.050 |
Why?
| Neuroimaging | 2 | 2017 | 278 | 0.050 |
Why?
| Death Certificates | 1 | 2023 | 31 | 0.050 |
Why?
| Calorimetry, Indirect | 1 | 2003 | 80 | 0.050 |
Why?
| Global Burden of Disease | 1 | 2023 | 18 | 0.050 |
Why?
| Transportation of Patients | 1 | 2023 | 50 | 0.050 |
Why?
| Hip Joint | 1 | 2024 | 157 | 0.050 |
Why?
| Conserved Sequence | 1 | 2003 | 227 | 0.050 |
Why?
| Mood Disorders | 1 | 2023 | 119 | 0.050 |
Why?
| Movement | 1 | 2025 | 269 | 0.050 |
Why?
| Drug Therapy, Combination | 2 | 2016 | 1009 | 0.050 |
Why?
| Accidental Falls | 1 | 2024 | 168 | 0.050 |
Why?
| Regional Blood Flow | 1 | 2024 | 459 | 0.050 |
Why?
| Personnel Turnover | 1 | 2022 | 38 | 0.050 |
Why?
| Needs Assessment | 1 | 2024 | 359 | 0.050 |
Why?
| Ohio | 1 | 2022 | 153 | 0.050 |
Why?
| Infant | 3 | 2024 | 8914 | 0.050 |
Why?
| Bacteremia | 1 | 2024 | 190 | 0.050 |
Why?
| Meta-Analysis as Topic | 1 | 2022 | 169 | 0.050 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2007 | 846 | 0.050 |
Why?
| Biomechanical Phenomena | 1 | 2024 | 777 | 0.050 |
Why?
| Policy | 1 | 2022 | 143 | 0.050 |
Why?
| Cause of Death | 1 | 2023 | 393 | 0.050 |
Why?
| Cost of Illness | 1 | 2023 | 277 | 0.040 |
Why?
| Headache | 1 | 2022 | 138 | 0.040 |
Why?
| Testosterone | 2 | 2023 | 373 | 0.040 |
Why?
| Postoperative Period | 1 | 2021 | 324 | 0.040 |
Why?
| Double-Blind Method | 2 | 2019 | 1848 | 0.040 |
Why?
| Anxiety Disorders | 1 | 2023 | 349 | 0.040 |
Why?
| Internet | 1 | 2024 | 617 | 0.040 |
Why?
| Job Satisfaction | 1 | 2022 | 201 | 0.040 |
Why?
| Obesity | 1 | 2013 | 2858 | 0.040 |
Why?
| Cervical Vertebrae | 1 | 2021 | 132 | 0.040 |
Why?
| Administrative Claims, Healthcare | 1 | 2020 | 26 | 0.040 |
Why?
| Cardiovascular Deconditioning | 1 | 2019 | 4 | 0.040 |
Why?
| Hyperacusis | 1 | 2019 | 7 | 0.040 |
Why?
| Photophobia | 1 | 2019 | 10 | 0.040 |
Why?
| Adrenal Cortex Hormones | 1 | 2023 | 518 | 0.040 |
Why?
| Ribonucleases | 1 | 1999 | 54 | 0.040 |
Why?
| Hypesthesia | 1 | 2019 | 16 | 0.040 |
Why?
| Education, Graduate | 1 | 2020 | 35 | 0.040 |
Why?
| Sleep | 2 | 2022 | 676 | 0.040 |
Why?
| Fee-for-Service Plans | 1 | 2020 | 88 | 0.040 |
Why?
| Dimensional Measurement Accuracy | 1 | 2019 | 13 | 0.040 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2013 | 2430 | 0.040 |
Why?
| Rehabilitation | 1 | 2019 | 16 | 0.040 |
Why?
| Inhalation Exposure | 1 | 1999 | 91 | 0.040 |
Why?
| Interleukin-8 | 1 | 2000 | 258 | 0.040 |
Why?
| Independent Living | 1 | 2020 | 98 | 0.040 |
Why?
| Pain | 1 | 2024 | 757 | 0.040 |
Why?
| Organizational Culture | 1 | 2020 | 138 | 0.040 |
Why?
| Ethanol | 1 | 2023 | 584 | 0.040 |
Why?
| Confidence Intervals | 1 | 2019 | 316 | 0.040 |
Why?
| RNA, Ribosomal, 16S | 1 | 2020 | 519 | 0.040 |
Why?
| Bacterial Infections | 1 | 2000 | 226 | 0.040 |
Why?
| Rhinitis | 1 | 1999 | 148 | 0.040 |
Why?
| Patient Admission | 1 | 2019 | 182 | 0.040 |
Why?
| Fetal Blood | 1 | 2000 | 316 | 0.040 |
Why?
| Energy Metabolism | 1 | 2003 | 831 | 0.040 |
Why?
| Reference Values | 1 | 2019 | 776 | 0.040 |
Why?
| Mobile Applications | 1 | 2020 | 159 | 0.040 |
Why?
| Emergency Medical Services | 1 | 2023 | 518 | 0.030 |
Why?
| Incidence | 1 | 2024 | 2616 | 0.030 |
Why?
| Disabled Persons | 1 | 2019 | 140 | 0.030 |
Why?
| Regression Analysis | 2 | 2003 | 978 | 0.030 |
Why?
| Feedback | 1 | 2017 | 159 | 0.030 |
Why?
| Child, Preschool | 2 | 2024 | 10384 | 0.030 |
Why?
| Self Care | 1 | 2020 | 368 | 0.030 |
Why?
| Prognosis | 2 | 2016 | 3772 | 0.030 |
Why?
| Public Health | 1 | 2021 | 482 | 0.030 |
Why?
| Monitoring, Physiologic | 1 | 2019 | 266 | 0.030 |
Why?
| Air Pollution | 1 | 1999 | 214 | 0.030 |
Why?
| Kaplan-Meier Estimate | 1 | 2019 | 853 | 0.030 |
Why?
| Organ Size | 1 | 2017 | 440 | 0.030 |
Why?
| Environmental Exposure | 1 | 2000 | 461 | 0.030 |
Why?
| Delivery of Health Care | 1 | 2023 | 895 | 0.030 |
Why?
| Task Performance and Analysis | 1 | 2017 | 173 | 0.030 |
Why?
| Wounds, Gunshot | 1 | 2019 | 213 | 0.030 |
Why?
| Predictive Value of Tests | 2 | 2016 | 1935 | 0.030 |
Why?
| Diet | 1 | 2023 | 1199 | 0.030 |
Why?
| Amygdala | 1 | 2017 | 186 | 0.030 |
Why?
| Patient Satisfaction | 1 | 2020 | 641 | 0.030 |
Why?
| Adaptation, Physiological | 1 | 1999 | 514 | 0.030 |
Why?
| Affect | 1 | 2018 | 285 | 0.030 |
Why?
| Psychological Tests | 1 | 2016 | 132 | 0.030 |
Why?
| Proportional Hazards Models | 1 | 2019 | 1196 | 0.030 |
Why?
| Personal Construct Theory | 1 | 2015 | 5 | 0.030 |
Why?
| Nevirapine | 1 | 2015 | 16 | 0.030 |
Why?
| Lamivudine | 1 | 2015 | 61 | 0.030 |
Why?
| Zidovudine | 1 | 2015 | 77 | 0.030 |
Why?
| Program Evaluation | 1 | 2019 | 874 | 0.030 |
Why?
| Reward | 1 | 2017 | 240 | 0.030 |
Why?
| Radiopharmaceuticals | 1 | 2015 | 166 | 0.030 |
Why?
| Drug Users | 1 | 2015 | 41 | 0.030 |
Why?
| Fluorodeoxyglucose F18 | 1 | 2015 | 127 | 0.030 |
Why?
| Healthy Volunteers | 1 | 2015 | 202 | 0.030 |
Why?
| Gene Expression | 1 | 2000 | 1456 | 0.030 |
Why?
| CD4 Lymphocyte Count | 1 | 2015 | 267 | 0.030 |
Why?
| Neutropenia | 1 | 2015 | 134 | 0.030 |
Why?
| Teaching Materials | 1 | 1994 | 23 | 0.030 |
Why?
| Nursing Evaluation Research | 1 | 1994 | 45 | 0.030 |
Why?
| Hospital Units | 1 | 2014 | 23 | 0.030 |
Why?
| Demography | 1 | 2015 | 277 | 0.030 |
Why?
| Positron-Emission Tomography | 1 | 2015 | 283 | 0.030 |
Why?
| Anti-Bacterial Agents | 1 | 2024 | 1663 | 0.030 |
Why?
| Substance Abuse, Intravenous | 1 | 2015 | 106 | 0.030 |
Why?
| Stress, Psychological | 1 | 2022 | 1060 | 0.030 |
Why?
| Research Design | 1 | 2020 | 1036 | 0.030 |
Why?
| Anemia | 1 | 2015 | 160 | 0.030 |
Why?
| Lipolysis | 1 | 2013 | 40 | 0.030 |
Why?
| Thrombocytopenia | 1 | 2015 | 181 | 0.030 |
Why?
| Patient Care Planning | 1 | 1994 | 149 | 0.030 |
Why?
| Curriculum | 1 | 2020 | 917 | 0.030 |
Why?
| Air Pollutants | 1 | 1997 | 312 | 0.030 |
Why?
| Sensitivity and Specificity | 2 | 2013 | 1815 | 0.030 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2014 | 236 | 0.030 |
Why?
| Pregnancy | 2 | 2016 | 6357 | 0.030 |
Why?
| Glucose Clamp Technique | 1 | 2013 | 194 | 0.030 |
Why?
| Fatty Acids, Nonesterified | 1 | 2013 | 159 | 0.030 |
Why?
| Adolescent Health Services | 1 | 2013 | 76 | 0.030 |
Why?
| Statistics as Topic | 1 | 2012 | 302 | 0.020 |
Why?
| Triglycerides | 1 | 2013 | 523 | 0.020 |
Why?
| Aggression | 1 | 2012 | 196 | 0.020 |
Why?
| Lung Diseases | 1 | 1997 | 715 | 0.020 |
Why?
| Diagnosis, Differential | 1 | 2014 | 1416 | 0.020 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2016 | 563 | 0.020 |
Why?
| Vital Capacity | 2 | 2000 | 288 | 0.020 |
Why?
| Lung | 1 | 2000 | 3743 | 0.020 |
Why?
| ADP-ribosyl Cyclase 1 | 1 | 2007 | 37 | 0.020 |
Why?
| Disease Progression | 1 | 2015 | 2602 | 0.020 |
Why?
| Receptors, CCR5 | 1 | 2007 | 57 | 0.020 |
Why?
| Forced Expiratory Volume | 2 | 2000 | 509 | 0.020 |
Why?
| Ki-67 Antigen | 1 | 2007 | 107 | 0.020 |
Why?
| Lewis X Antigen | 1 | 2006 | 4 | 0.020 |
Why?
| Fluorescent Antibody Technique | 1 | 2007 | 371 | 0.020 |
Why?
| Deer | 1 | 2006 | 30 | 0.020 |
Why?
| Antiretroviral Therapy, Highly Active | 1 | 2008 | 266 | 0.020 |
Why?
| Immunophenotyping | 1 | 2007 | 311 | 0.020 |
Why?
| Viral Load | 1 | 2007 | 450 | 0.020 |
Why?
| Body Mass Index | 1 | 2013 | 2261 | 0.010 |
Why?
| Microscopy, Fluorescence | 1 | 2006 | 399 | 0.010 |
Why?
| Immune Sera | 1 | 1984 | 86 | 0.010 |
Why?
| Acute Disease | 1 | 2007 | 964 | 0.010 |
Why?
| Ovulation | 1 | 1984 | 40 | 0.010 |
Why?
| Immunization, Passive | 1 | 1984 | 85 | 0.010 |
Why?
| HLA-A3 Antigen | 1 | 2003 | 5 | 0.010 |
Why?
| HLA-B7 Antigen | 1 | 2003 | 6 | 0.010 |
Why?
| HLA-A2 Antigen | 1 | 2003 | 47 | 0.010 |
Why?
| Superantigens | 1 | 2003 | 70 | 0.010 |
Why?
| Lymph Nodes | 1 | 2006 | 466 | 0.010 |
Why?
| Flow Cytometry | 1 | 2007 | 1142 | 0.010 |
Why?
| Histocompatibility Testing | 1 | 2003 | 120 | 0.010 |
Why?
| Cell Line, Transformed | 1 | 2003 | 140 | 0.010 |
Why?
| Lymphocyte Activation | 1 | 2007 | 1098 | 0.010 |
Why?
| Blood Glucose | 1 | 2013 | 2093 | 0.010 |
Why?
| Gonadal Steroid Hormones | 1 | 1984 | 129 | 0.010 |
Why?
| Amino Acid Motifs | 1 | 2003 | 209 | 0.010 |
Why?
| Drug Evaluation, Preclinical | 1 | 2003 | 168 | 0.010 |
Why?
| Basal Metabolism | 1 | 2003 | 57 | 0.010 |
Why?
| Immunohistochemistry | 1 | 2006 | 1664 | 0.010 |
Why?
| Brain | 1 | 2014 | 2620 | 0.010 |
Why?
| Inflammation | 2 | 2006 | 2654 | 0.010 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 815 | 0.010 |
Why?
| Leukocytes, Mononuclear | 1 | 2003 | 539 | 0.010 |
Why?
| Nasal Lavage Fluid | 1 | 1999 | 14 | 0.010 |
Why?
| Eosinophil Granule Proteins | 1 | 1999 | 21 | 0.010 |
Why?
| Body Composition | 1 | 2003 | 644 | 0.010 |
Why?
| Albumins | 1 | 1999 | 101 | 0.010 |
Why?
| Nasal Mucosa | 1 | 1999 | 107 | 0.010 |
Why?
| Leukocyte Count | 1 | 1999 | 325 | 0.010 |
Why?
| Biomarkers | 2 | 2000 | 3880 | 0.010 |
Why?
| Mice, Transgenic | 1 | 2003 | 2071 | 0.010 |
Why?
| Interleukins | 1 | 2000 | 242 | 0.010 |
Why?
| Leukocytes | 1 | 1999 | 303 | 0.010 |
Why?
| Blood Proteins | 1 | 1999 | 239 | 0.010 |
Why?
| Urban Health | 1 | 1997 | 79 | 0.010 |
Why?
| Polymerase Chain Reaction | 1 | 2000 | 1020 | 0.010 |
Why?
| Eosinophils | 1 | 1999 | 323 | 0.010 |
Why?
| Animals | 3 | 2006 | 34479 | 0.010 |
Why?
| Linear Models | 1 | 1997 | 813 | 0.010 |
Why?
| RNA, Messenger | 1 | 2000 | 2675 | 0.010 |
Why?
| Students | 1 | 1997 | 572 | 0.010 |
Why?
| Mice | 1 | 2003 | 16602 | 0.000 |
Why?
| Androstenedione | 1 | 1984 | 11 | 0.000 |
Why?
| Estrone | 1 | 1984 | 36 | 0.000 |
Why?
| Sheep | 1 | 1984 | 828 | 0.000 |
Why?
| Estradiol | 1 | 1984 | 486 | 0.000 |
Why?
|
|
Forster's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|